Eligibility-screened, exclusive mass tort claimants, priced your way: per lead from $250 on Depo-Provera, or per signed case on a CPA model. Our campaigns run about a third below industry benchmark CPL.
Get a CPL or CPA Quote by Tort
Shared tort leads mean your intake team races other firms to a claimant who has already told their story twice today.
Wrong product, wrong dates, existing representation, discovered after your intake team burned twenty minutes per name.
As a tort matures, the auction crowds and lazy vendors pass the inflation straight through to your firm.
Creative that plays loose with attorney advertising rules puts your bar card next to somebody else's shortcuts.
Buy qualified claimant leads on CPL, or buy signed retainers on CPA. Both models are priced in writing before launch.
Qualified claimant leads at a per-lead price set by tort and screening depth. Depo-Provera claimant leads start at $250; other torts are quoted on claimant scarcity and criteria. Across our mass tort campaigns, CPLs have held roughly a third below accepted industry benchmarks.
Pricing tied to signed cases instead of leads: we carry the qualification and volume risk, you pay for outcomes. Case criteria, intake handoff, and reporting are agreed in writing upfront. CPA works best once a tort has baseline volume data, which a CPL phase establishes.
Over ten thousand qualified claimants matched to litigation partners at scale, with signed-case-ready leads delivered about 32% below benchmark CPL for a mass tort firm. The models are different ways to buy the same proven funnel.
Mass tort is the deepest vertical of our lead generation service, with the same rules everywhere: exclusive, screened, and accountable to the case.
Depo-Provera, Roundup, talcum, and emerging torts, each with creative and screening built to that tort's eligibility profile, not a generic injury template.
Product usage, diagnosis, treatment dates, and prior representation screened by smart-logic questions before a claimant ever becomes a billable lead.
Buy qualified claimant leads at a per-lead price, or buy outcomes with pricing tied to signed retainers. Most firms start on CPL and graduate to CPA once volume data exists.
Disclaimers, sensitive-topic handling, and platform policy navigation baked into every creative, because your bar license rides on our ad account.
Real-time delivery into your intake platform or CRM, with speed-to-contact tracking, because a claimant contacted in five minutes signs and one contacted tomorrow does not.
Sign rates feed back into targeting weekly, and volume forecasting by tort keeps your case acquisition budget mapped to docket timelines.
Cheap tort leads are expensive cases. Three disciplines keep the math working through to retainer.
A mass tort lead is only worth its eligibility. Smart-logic screening runs the tort criteria in the ad funnel itself, so unqualified claimants cost us ad spend instead of costing you intake hours and lead fees.
Every claimant is delivered to one firm, contractually. Sign rates collapse when a claimant has already retained whoever called first, which is why shared tort leads are expensive at any price.
Whether you buy leads or signed cases, the economics are tracked through to retainer. When cost per signed case is the number on the dashboard, both sides optimize for the same thing.
Lead disputes and billing arguments come from missing records. Our client portal keeps every claimant timestamped, source-tagged, and reconciled against billing, next to the campaign breakdowns and optimization log.
Every lead timestamped, source-tagged, and reconciled against billing.
Volume, CPL, and qualification rate split by campaign and creative in your portal.
Retainer outcomes flow back into targeting, so claimant quality compounds.
CPL, contact rate, and cost per signed case in plain English, weekly.
Law firms and litigation partners running on screened, exclusive claimant flow.
Qualification-first ad creative and daily manual optimization delivered signed-case-ready claimant leads well under the accepted industry benchmark.
High-volume campaigns with built-in eligibility screening matched thousands of qualified claimants to litigation partners at scale.
A full-funnel rebuild across search and social tripled qualified case inquiries while intake staff finally knew which channel every lead came from.
Target torts, eligibility criteria, and case profile defined with your intake and litigation team.
CPL for volume with your intake closing, or signed-case CPA once baseline data supports it. Pricing in writing.
Creative, disclaimers, screening flows, and intake delivery built and reviewed before launch.
Every campaign and screening question reviewed with your firm before a dollar is spent.
Claimants land in your intake platform in real time while targeting tunes against sign rates.
Volume scales with docket timelines and your intake capacity, never past the point quality holds.
No add-on fees for the fundamentals. These come standard on every mass tort engagement.
Get a Quote by Tortarrow_outwardThe traffic engines and the full program behind this vertical.
The volume engine behind our mass tort intake, with qualification-first creative and published CPL benchmarks across legal and home services.
Explore Facebook adsarrow_forwardfact_checkThe full program: personal injury and MVA leads from $200, home services, and every pricing model on one page.
Explore lead generationarrow_forwardPricing is set per tort and per intake criteria. Depo-Provera claimant leads start at $250 per lead with usage, diagnosis, and eligibility screened in-form; other torts are quoted based on claimant scarcity, screening depth, and volume. Across our mass tort campaigns, CPLs have held roughly a third below accepted industry benchmarks, and every quote is in writing before launch.
CPL suits firms with strong intake operations that want volume and control: you pay per qualified claimant and your team converts them. Signed-case CPA suits firms that want outcome pricing: we carry the qualification burden and you pay per retainer. Most engagements start on CPL to establish sign-rate data, then graduate to CPA once both sides can price the outcome honestly.
Active dockets including Depo-Provera, Roundup, and talcum powder, plus emerging torts as they develop. Each tort gets its own creative, eligibility screening, and volume forecast rather than a recycled injury template. If a tort is oversaturated or its claimant economics do not work for your criteria, we say so before you spend.
Attorney advertising disclaimers on every creative, sensitive-topic handling that meets platform policy, no outcome promises, and claims language reviewed against the rules of the jurisdictions you practice in. Compliance is built into the creative process, not patched after a bar complaint.
Yes, contractually. Every claimant is generated for your firm and delivered only to you: never shared, never resold, never recycled to another firm later. Exclusivity is the single biggest driver of sign rate, because a claimant who has already retained cannot retain you.
In real time, into your intake platform, CRM, or a shared ledger, timestamped and source-tagged, with speed-to-contact tracking because contact within minutes is what converts screening into retainers. Disputed leads go through a documented return process, and dispute patterns feed straight back into campaign optimization.
Book a call. We will quote CPL and signed-case CPA side by side for your tort, map realistic claimant volume, and show you the screening flow before you commit.